We provide biomedical scientific services focused on natural extracts and organic ingredients. 3Sixty Biomedicine is committed to providing world class innovative healthcare solutions to the global market. 3Sixty Biomedicine has partnered with industry leaders to realise the vision of “improving livelihoods, improving lives”.
3Sixty Biomedicine is a subsidiary of 3Sixty Global Solutions Group, formerly known as 3Sixty Financial Services Group, a leading diversified business conglomerate with interests in funeral, financial, healthcare, scientific, technology and client services. The Group emerged from Doves Group, grew into a financial services group and has ventured into biotechnology.
3Sixty Biomedicine is a young and ambitious company. The business was officially registered in 2019 and it already has a few products in the market and many more in the pipeline.
3Sixty Biomedicine acquired Troy Pharmaceuticals in the same year. Troy Pharmaceuticals is based in Kwa-Zulu Natal and has been in business for over a decade. It manufactures and commercialises herbal and traditional based medicines and products. 3Sixty Biomedicine is also affiliated with another biotech company, 3Sixty Biopharmaceuticals, which focuses on innovative allopathic medicines targeted at providing solutions to South Africa’s health care problems, such as infectious diseases.
3Sixty Biomedicine Directors
CEO 3Sixty Biomedicine
Dr Osborn Mahanjana
Ms Olu Luthaga
Dr. Criselda Kananda
Adv Tebogo Moshakga
Group Company Secretary